NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/21/2025
Back to search
Official data from USPTO
DELTEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
DELTEX
ST13
US500000090563497Class
5, 42, 44
Filing
90563497
Registration
7995024
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
57
Latest update
10/22/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 42, 44
Filing date
03/05/2021
Registration date
10/21/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
10/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/24/2021
First use in commerce
02/24/2021
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
SALCIDO,JOHN CHARLES
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
In8bio, Inc.
Representatives
Mark Jansen FENWICK & WEST LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals in the nature of cell therapeutics for the treatment and prevention of cancer; engineered cell therapiesengineered T cellsimmune cellsantibodies for the treatment and prevention of cancer
Class 42
Medical research and development; Research and development of pharmaceuticals; Research and development in the field of bioengineering and genetic engineering; Research and development of treatments and therapies in the field of oncology; Research and development of pharmaceuticals for the treatment and prevention of cancerautoimmuneinflammatoryinfectious diseases and disorders; Scientific research for medical purposes in the field of cancerautoimmuneinflammatoryinfectious diseases and disorders; Molecularcellulargenetic research and development; Development of processes and methods for the manufacturing and engineering of cells and molecules; development of therapeutics and treatments for the prevention of cancerautoimmuneinflammatorygenetic and infectious diseases and disorders
Class 44
Providing health information; Providing health information in the field of bioengineering and genetic engineering; Providing health information in the field of autoimmuneinflammatory and infectious diseases and disorderscancer prevention and treatment
Publications
History of USPTO decisions and trademark events.
57 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/21/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
10/01/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
10/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/01/2025
ALIE
ASSIGNED TO LIE
10/01/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/25/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06/23/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
06/23/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/25/2025
GNRT
NON-FINAL ACTION E-MAILED
03/25/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
03/25/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/18/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/10/2025
IUAF
USE AMENDMENT FILED
01/03/2025
EISU
TEAS STATEMENT OF USE RECEIVED
01/03/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/21/2024
EX5G
SOU EXTENSION 5 GRANTED
06/21/2024
EXT5
SOU EXTENSION 5 FILED
06/21/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/21/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/19/2023
EX4G
SOU EXTENSION 4 GRANTED
12/15/2023
EXT4
SOU EXTENSION 4 FILED
12/15/2023
EEXT
SOU TEAS EXTENSION RECEIVED
12/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/28/2023
EX3G
SOU EXTENSION 3 GRANTED
06/26/2023
EXT3
SOU EXTENSION 3 FILED
06/26/2023
EEXT
SOU TEAS EXTENSION RECEIVED
06/26/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/05/2023
EX2G
SOU EXTENSION 2 GRANTED
01/03/2023
EXT2
SOU EXTENSION 2 FILED
01/03/2023
EEXT
SOU TEAS EXTENSION RECEIVED
01/03/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/07/2022
EX1G
SOU EXTENSION 1 GRANTED
07/05/2022
EXT1
SOU EXTENSION 1 FILED
07/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
07/05/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/04/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/09/2021
PUBO
PUBLISHED FOR OPPOSITION
11/09/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/20/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/05/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/05/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/04/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/04/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/30/2021
GNRT
NON-FINAL ACTION E-MAILED
09/30/2021
CNRT
NON-FINAL ACTION WRITTEN
09/30/2021
DOCK
ASSIGNED TO EXAMINER
09/27/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/03/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/03/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2021
NWAP
NEW APPLICATION ENTERED
03/09/2021
Continuous trademark protection
Get notified about every new filing that threatens DELTEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.